Apotheek Uilenberg: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Apotheek Uilenberg
Largest movements
- Tangible fixed assets -€40,986
down €40,986 (-6.4%), from €637,145 to €596,159
of which Land and buildings: -€25,622
- Receivables within one year +€13,758
up €13,758 (+520.3%), from €2,644 to €16,403
of which Trade receivables: +€16,367
- Cash -€11,446
down €11,446 (-59.4%), from €19,258 to €7,812
mainly Net result for the year (-€142,558) and Debts after one year (-€64,277)
- Profit (loss) carried forward -€142,558
down €142,558 (-90.6%), from -€157,283 to -€299,841
- Other debts +€130,000
up €130,000 (+95.6%), from €136,019 to €266,019
- Debts after one year -€64,277
down €64,277 (-9.7%), from €663,794 to €599,516
- Trade debts +€33,035
up €33,035 (+270.1%), from €12,230 to €45,264
- Tax, wage and social debts +€9,239
new in 2025: €9,239
- Gross operating margin -€77,254
down €77,254, from €61,836 to -€15,418
- Staff costs -€8,567
down €8,567 (-13.0%), from €65,825 to €57,258
- Other operating charges +€2,204
up €2,204 (+387.2%), from €569 to €2,773
- Financial charges -€1,142
down €1,142 (-6.4%), from €17,768 to €16,626
- Depreciation +€911
up €911 (+1.8%), from €49,571 to €50,483
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €725,986 | €689,137 | -€36,850 | -5.1% |
| Fixed assets | 21/28 | €637,145 | €596,309 | -€40,836 | -6.4% |
| Tangible fixed assets | 22/27 | €637,145 | €596,159 | -€40,986 | -6.4% |
| Land and buildings | 22 | €572,374 | €546,753 | -€25,622 | -4.5% |
| Plant, machinery and equipment | 23 | €64,771 | €49,406 | -€15,365 | -23.7% |
| Financial fixed assets | 28 | - | €150 | +€150 | |
| Current assets | 29/58 | €88,841 | €92,828 | +€3,987 | +4.5% |
| Stocks and contracts in progress | 3 | €66,939 | €68,574 | +€1,636 | +2.4% |
| Stocks | 30/36 | €66,939 | €68,574 | +€1,636 | +2.4% |
| Amounts receivable within one year | 40/41 | €2,644 | €16,403 | +€13,758 | +520.3% |
| Trade receivables | 40 | - | €16,367 | +€16,367 | |
| Other amounts receivable | 41 | €2,644 | €35 | -€2,609 | -98.7% |
| Cash at bank and in hand | 54/58 | €19,258 | €7,812 | -€11,446 | -59.4% |
| Deferred charges and accrued income | 490/1 | - | €38 | +€38 | |
| Total equity and liabilities | 10/49 | €725,986 | €689,137 | -€36,850 | -5.1% |
| Equity | 10/15 | -€147,283 | -€289,841 | -€142,558 | -96.8% |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€157,283 | -€299,841 | -€142,558 | -90.6% |
| Amounts payable | 17/49 | €873,269 | €978,978 | +€105,709 | +12.1% |
| Amounts payable after more than one year | 17 | €663,794 | €599,516 | -€64,277 | -9.7% |
| Financial debts | 170/4 | €663,794 | €599,516 | -€64,277 | -9.7% |
| Amounts payable within one year | 42/48 | €209,475 | €379,462 | +€169,986 | +81.1% |
| Current portion of amounts payable after more than one year | 42 | €61,227 | €58,939 | -€2,287 | -3.7% |
| Trade debts | 44 | €12,230 | €45,264 | +€33,035 | +270.1% |
| Suppliers | 440/4 | €12,230 | €45,264 | +€33,035 | +270.1% |
| Taxes, remuneration and social security | 45 | - | €9,239 | +€9,239 | |
| Remuneration and social security | 454/9 | - | €9,239 | +€9,239 | |
| Other amounts payable | 47/48 | €136,019 | €266,019 | +€130,000 | +95.6% |
| Remuneration, social security and pensions | 62 | €65,825 | €57,258 | -€8,567 | -13.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €49,571 | €50,483 | +€911 | +1.8% |
| Other operating charges | 640/8 | €569 | €2,773 | +€2,204 | +387.2% |
| Gross operating margin | 9900 | €61,836 | -€15,418 | -€77,254 | |
| Operating profit (loss) | 9901 | -€54,130 | -€125,932 | -€71,802 | -132.6% |
| Financial income | 75/76B | €228 | €0 | -€228 | -100.0% |
| Recurring financial income | 75 | €228 | €0 | -€228 | -100.0% |
| Financial charges | 65/66B | €17,768 | €16,626 | -€1,142 | -6.4% |
| Recurring financial charges | 65 | €17,768 | €16,626 | -€1,142 | -6.4% |
| Profit (loss) for the period before taxes | 9903 | -€71,671 | -€142,558 | -€70,888 | -98.9% |
| Profit (loss) for the period | 9904 | -€71,671 | -€142,558 | -€70,888 | -98.9% |
| Profit (loss) for the period to be appropriated | 9905 | -€71,671 | -€142,558 | -€70,888 | -98.9% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.